Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
44.36
+0.19 (0.43%)
At close: Feb 27, 2026
SHA:688799 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 177.74 | 379.65 | 191.29 | 353.39 |
Short-Term Investments | - | 296.78 | 349.66 | 181.66 | - |
Trading Asset Securities | - | 183 | 15 | 325 | 400 |
Cash & Short-Term Investments | 295.94 | 657.52 | 744.31 | 697.95 | 753.39 |
Cash Growth | -54.99% | -11.66% | 6.64% | -7.36% | 853.42% |
Accounts Receivable | - | 226.19 | 183.54 | 180.54 | 129.2 |
Other Receivables | - | 16.5 | 2.14 | 2.19 | 1.49 |
Receivables | - | 242.69 | 185.68 | 182.73 | 130.68 |
Inventory | - | 412.43 | 362.67 | 339.26 | 300.53 |
Prepaid Expenses | - | 2.48 | 1.11 | 1.83 | 2.49 |
Other Current Assets | - | 118.15 | 55.98 | 26.57 | 18.89 |
Total Current Assets | - | 1,433 | 1,350 | 1,248 | 1,206 |
Property, Plant & Equipment | - | 687 | 596.78 | 563.76 | 472.98 |
Long-Term Investments | - | 43.49 | 47.15 | 36.05 | 34.11 |
Goodwill | - | 32.38 | 32.38 | 32.38 | - |
Other Intangible Assets | - | 186.09 | 76.62 | 81.06 | 57.56 |
Long-Term Deferred Tax Assets | - | 39.81 | 18.73 | 14.2 | 12.29 |
Long-Term Deferred Charges | - | 10.44 | 5.32 | 3.26 | 0.23 |
Other Long-Term Assets | - | 27.14 | 50.21 | 29.92 | 14.38 |
Total Assets | - | 2,460 | 2,177 | 2,009 | 1,798 |
Accounts Payable | - | 139.92 | 89.5 | 71.13 | 80.9 |
Accrued Expenses | - | 24.51 | 26.04 | 20.61 | 72.81 |
Short-Term Debt | - | 3.77 | - | - | - |
Current Portion of Long-Term Debt | - | 0.05 | 0.01 | - | - |
Current Income Taxes Payable | - | 13.32 | 9.97 | 1.29 | 0.94 |
Current Unearned Revenue | - | 88.99 | 80.13 | 82.41 | 62.75 |
Other Current Liabilities | - | 148.46 | 130.73 | 119.4 | 42.19 |
Total Current Liabilities | - | 419.02 | 336.38 | 294.83 | 259.59 |
Long-Term Debt | - | 113.93 | 17.11 | - | - |
Long-Term Unearned Revenue | - | 98.8 | 49.94 | 53.19 | 56.92 |
Long-Term Deferred Tax Liabilities | - | 0.02 | - | 2.33 | 0.01 |
Other Long-Term Liabilities | - | 5.28 | 5.28 | - | 1.55 |
Total Liabilities | - | 637.06 | 408.7 | 350.35 | 318.07 |
Common Stock | - | 93.8 | 93.8 | 93.8 | 93.8 |
Additional Paid-In Capital | - | 850.34 | 850.34 | 850.34 | 850.34 |
Retained Earnings | - | 859.27 | 779.37 | 652.47 | 535.33 |
Total Common Equity | 1,992 | 1,803 | 1,724 | 1,597 | 1,479 |
Minority Interest | - | 19.17 | 44.73 | 62.01 | - |
Shareholders' Equity | 1,992 | 1,823 | 1,768 | 1,659 | 1,479 |
Total Liabilities & Equity | - | 2,460 | 2,177 | 2,009 | 1,798 |
Total Debt | 352.41 | 117.75 | 17.12 | - | - |
Net Cash (Debt) | -56.47 | 539.77 | 727.19 | 697.95 | 753.39 |
Net Cash Growth | - | -25.77% | 4.19% | -7.36% | 853.42% |
Net Cash Per Share | -0.43 | 4.11 | 5.53 | 5.32 | 6.73 |
Filing Date Shares Outstanding | 131.32 | 131.32 | 131.32 | 131.32 | 131.32 |
Total Common Shares Outstanding | 131.32 | 131.32 | 131.32 | 131.32 | 131.32 |
Working Capital | - | 1,014 | 1,013 | 953.5 | 946.38 |
Book Value Per Share | 15.17 | 13.73 | 13.12 | 12.16 | 11.27 |
Tangible Book Value | 1,827 | 1,585 | 1,615 | 1,483 | 1,422 |
Tangible Book Value Per Share | 13.91 | 12.07 | 12.29 | 11.29 | 10.83 |
Buildings | - | 329.86 | 325.35 | 313.1 | 304.86 |
Machinery | - | 526.21 | 491.33 | 372.49 | 274.63 |
Construction In Progress | - | 143.06 | 27.62 | 70.5 | 43.05 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.